Difficulty: Medium
Average Score: 72%
Practice
Tick the drug with nonselective beta-adrenoblocking activity:
Correct answer
B
Rationale
In this pharmacology/lifespan considerations exam question, the correct answer is B) Propranolol, as it is a drug with nonselective beta-adrenoblocking activity.
Propranolol is a nonselective beta-blocker, meaning it blocks both beta-1 and beta-2 adrenergic receptors. This results in effects such as decreased heart rate, reduced blood pressure, and bronchoconstriction. It is commonly used to treat conditions like hypertension, angina, and arrhythmias.
A) Atenolol is a selective beta-1 adrenergic receptor blocker, primarily affecting the heart. It is often used in conditions like hypertension and angina, but it does not have the nonselective activity of propranolol.
C) Metoprolol is another selective beta-1 adrenergic receptor blocker, commonly used for conditions like hypertension, angina, and heart failure. It does not possess the nonselective activity of propranolol.
D) Nebivolol is a selective beta-1 adrenergic receptor blocker with vasodilatory properties. It is used in conditions like hypertension and heart failure but does not exhibit the nonselective beta-adrenoblocking activity of propranolol.
Understanding the differences between selective and nonselective beta-blockers is crucial in pharmacology practice, as it impacts their therapeutic uses, side effect profiles, and contraindications. This knowledge is essential for healthcare professionals to make informed decisions when prescribing these medications to patients of different age groups across the lifespan.
Propranolol is a nonselective beta-blocker, meaning it blocks both beta-1 and beta-2 adrenergic receptors. This results in effects such as decreased heart rate, reduced blood pressure, and bronchoconstriction. It is commonly used to treat conditions like hypertension, angina, and arrhythmias.
A) Atenolol is a selective beta-1 adrenergic receptor blocker, primarily affecting the heart. It is often used in conditions like hypertension and angina, but it does not have the nonselective activity of propranolol.
C) Metoprolol is another selective beta-1 adrenergic receptor blocker, commonly used for conditions like hypertension, angina, and heart failure. It does not possess the nonselective activity of propranolol.
D) Nebivolol is a selective beta-1 adrenergic receptor blocker with vasodilatory properties. It is used in conditions like hypertension and heart failure but does not exhibit the nonselective beta-adrenoblocking activity of propranolol.
Understanding the differences between selective and nonselective beta-blockers is crucial in pharmacology practice, as it impacts their therapeutic uses, side effect profiles, and contraindications. This knowledge is essential for healthcare professionals to make informed decisions when prescribing these medications to patients of different age groups across the lifespan.